1291eP Pola-R-CHP regimen as first-line treatment for newly diagnosed high-risk diffuse large B-cell lymphoma (DLBCL) patients.
Saved in:
| Title: | 1291eP Pola-R-CHP regimen as first-line treatment for newly diagnosed high-risk diffuse large B-cell lymphoma (DLBCL) patients. |
|---|---|
| Authors: | Pi, J.1 (AUTHOR), He, X.2 (AUTHOR), Zhou, S.2 (AUTHOR), Liu, P.2 (AUTHOR), Yang, J.2 (AUTHOR), Wei, G.1 (AUTHOR), Wang, T.1 (AUTHOR), Jin, J.1 (AUTHOR), Lin, Y.1 (AUTHOR), Lv, Q.1 (AUTHOR), Zhang, W.1 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS814-S815. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2025.08.1925 |
